New Non-Invasive Method In Lung DiagnosticsJune 24, 2004Magnetic resonance imaging (MRI) as a non-invasive diagnostic method has been evolving into an attractive alternative to methods which are associated with radiation exposure. This development now also starts to manifest itself in lung perfusion imaging. This was reported by Dr. Christian Fink and colleagues of the Radiology Division of the Deutsches Krebsforschungszentrum (German Cancer Research Center) in a recent issue of the journal Radiology*. Diagnosis of numerous diseases of the lungs requires precise imaging of lung perfusion. The standard method used is called perfusion scintigraphy. It involves injecting a radioactive substance into a patient's bloodstream and then making a scan of its distribution in the lungs. An equally precise and absolutely radiation-free method for evaluating lung perfusion now turns out to be magnetic resonance imaging (MRI, also called nuclear magnetic resonance (NMR) scan). In a comparative study of 7 healthy probands and 20 patients with suspected lung cancer, the researchers compared magnetic resonance imaging to the standard method of perfusion scintigraphy. MRI showed a higher temporal and spatial resolution in lung perfusion imaging and provides the additional advantage of three-dimensional image data, which makes it easier to recognize blood circulation changes. Perfusion defects caused by tumors were recognized with high accuracy. In direct comparison with the standard method, MRI was found to be at least equally good. It is too early yet for MRI to become a routine clinical method of lung perfusion imaging. The value of the new method first needs to be assessed in larger studies. But the investigators are optimistic that the radiation-free option may turn into the method of choice: "Image resolution in MRI is about twice as high as in perfusion scintigraphy so that we expect a higher detail precision compared to the standard method", says Fink. Alongside evaluation of perfusion, MRI also provides additional information, e.g. about the anatomy of blood vessels in the lungs and the temporal process of lung perfusion. Thus, it provides insight about both vessel organization and function of blood circulation down to the tiniest branches of the lungs. The method can be used not only in diagnostics and surgery planning for lung tumor patients. It may in future also be beneficial in non-invasive diagnostics of other lung diseases such as pulmonary embolism, emphysema, and chronic bronchitis. Presently, however, MRI is substantially more expensive than the standard method (approx. 300 euros versus 75 euros per examination), since the remuneration system does not yet take adequate account of innovative methods of this kind. The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis, and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research (BMBF) and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V., HGF). | |||||||||||||||||||||
|
Related Cancer Current Events and Cancer News Articles Deaths from lung cancer could be reduced by better policies to control indoor radon About 1100 people each year die in the UK from lung cancer related to indoor radon, but current government protection policies focus mainly on the small number of homes with high radon levels and neglect the 95% of radon related deaths caused by lower levels of radon, according to a study published on bmj.com today. Protein's essential role in repairing damaged cells revealed University of Michigan researchers have discovered that a key protein in cells plays a critical role in not one, but two processes affecting the development of cancer. Interpretation Time for Screening Digital Mammograms: Is it Efficient? Digital mammograms take longer to interpret than film-screen mammograms, according to a study performed at The University of Texas M.D. Anderson Cancer Center in Houston, Texas. Scientists can now differentiate between healthy cells and cancer cells One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. Team finds breast cancer gene linked to disease spread A team of researchers at Princeton University and The Cancer Institute of New Jersey has identified a long-sought gene that is fatefully switched on in 30 to 40 percent of all breast cancer patients, spreading the disease, resisting traditional chemotherapies and eventually leading to death. New hope for cancer comes straight from the heart Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today. In the Dec. 16 issue of the Proceedings of the National Academy of Sciences, researchers at the Johns Hopkins University School of Medicine now report that this same class of drugs may hold new promise as a treatment for cancer. Cell Biologists Identify New Tumor Suppressor for Lung Cancer Cancer and cell biology experts at the University of Cincinnati (UC) have identified a new tumor suppressor that may help scientists develop more targeted drug therapies to combat lung cancer. Errors involving medications common in outpatient cancer treatment Seven percent of adults and 19 percent of children taking chemotherapy drugs in outpatient clinics or at home were given the wrong dose or experienced other mistakes involving their medications. Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, according to researchers from the University of Kentucky. They found that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract. In lung cancer, silencing one crucial gene disrupts normal functioning of genome While examining patterns of DNA modification in lung cancer, a team of international researchers has discovered what they say is a surprising new mechanism. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||